Newsroom

Researchers from the HZI and CSSB discuss the latest technologies in infection research.

News

On 29 November 2024, a matchmaking workshop between scientists of the Helmholtz Centre for Infection Research (HZI) and the Centre for Structural Systems Biology (CSSB) in Hamburg was held at the HZI campus in Braunschweig, bringing together about 50 researchers from Braunschweig, Hannover, Würzburg and Hamburg. CSSB was established in Hamburg as a joint initiative of ten northern German research partners, including the HZI, and is an interdisciplinary center where biologists, chemists, physicians, physicists and engineers explore the interaction of pathogens with their hosts. The event featured flash talks by early-career researchers and PIs, as well as poster pitches and in-depth presentations of the core facilities at HZI in Braunschweig and CSSB in Hamburg.

04.12.2024

HZI Campus

CSSB

Interview

A conversation with Prof. Andreas Keller from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Prof. Yang Li from the Centre for Individualised Infection Medicine (CiiM) about artificial intelligence (AI) in individualized infection medicine.

28.11.2024

HIPS

CiiM

Interview

Veterinarian Dr. Fee Zimmermann collects long-term data on human, animal and environmental health in the African tropics and on her doorstep - in Mecklenburg-Western Pomerania. She heads a research group at the Helmholtz Institute for One Health (HIOH) in Greifswald. In this interview, she talks about the importance of the tropics for future disease outbreaks and about animal helpers in data collection.

28.11.2024

HIOH

Story

Strengthening our microbiome with a pill so that it can effectively fight diseases? HZI researchers are striving to make this vision of the future a reality.

22.11.2024

HZI Campus

Highly cited researchers from the HZI: Andreas Keller (©HIPS/Oliver Dietze), Josef Penninger (©HZI/Verena Meier) and Marc Stadler (©HZI/Verena Meier).

News

Every year, the company Clarivate Analytics publishes a list of "Highly Cited Researchers" and honors scientists who have made a particularly significant impact on their fields. In 2024, researchers from the Helmholtz Centre for Infection Research (HZI) are once again among them: This time, bioinformatician Prof. Andreas Keller, Scientific Director of the HZI and geneticist Prof. Josef Penninger and biotechnologist Prof. Marc Stadler were honored for their scientific publications.

21.11.2024

HZI Campus

News

Antibacterial drugs are important to treat infections. But increasing bacterial resistance to current drugs — making them ineffective or only partially effective — means that new ones are urgently needed. Building on previous work, researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), together with an international team of collaborators, have demonstrated a potential antibacterial treatment from a biosynthetic derivative of darobactin, a bacterial natural product. The team reports proof-of-concept animal trials on infections caused by bacteria, including Escherichia coli and Acinetobacter baumannii that are known to develop drug-resistance. This ACS Infectious Diseases study was published during the World Health Organization’s World Antimicrobial Resistance (AMR) Awareness Week from 18 to 24 November 2024. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.

20.11.2024

HZI Campus

HIPS

Back to the first page
...
15
16
17
18
...
148

HZI in the media

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

Earlier in 2025, for

10.11.2025

The Press

Hochschule Hannover, die Universitätsmedizin Göttingen, das Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die KI-

07.11.2025

Heise online

... , Leiter der Forschungsgruppe Mikrobielle Wirkstoffe am Helmholtz-Zentrum für Infektionsforschung, zu bedenken. Das erste ...

07.11.2025

Leipziger Volkszeitung (LVZ)

Quelle: Pressemitteilung

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025

LaborPraxis

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025

Arbeitsmedizin-Sozialmedizin-Umweltmedizin

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025

Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025

bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025

MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025

innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025

Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025

Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025

PROCESS

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.